S&P Futures
3,812.75 -8.50 (-0.22%) Dow Futures
30,947.00 -52.00 (-0.17%) Nasdaq Futures
11,660.75 -30.25 (-0.26%) Russell 2000 Futures
1,717.90 -3.50 (-0.20%) Crude Oil
110.20 +0.42 (+0.38%) Gold
1,820.80 +3.30 (+0.18%)
Item 9 Labs Corp. (INLB)
- PR Newswire
Item 9 Labs Corp. Nears Completion of Cannabis Cultivation and Lab Facility in Pahrump, Nevada
Item 9 Labs Corp. (OTCQX: INLB) (the "Company")—a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products—is pleased to announce today that its new 20,000 square-foot, state-of-the-art cultivation and lab facility in Pahrump, N.V. (the "Nevada Facility") is nearing completion and expected to be fully operational by end of 2022.
- MarketWatch
U.S. cannabis company Item 9 Labs buys Canada's Sessions Cannabis
Phoenix-based Item 9 Labs Corp. said Wednesday it'll pay an undisclosed sum to acquire Canada's Sessions Cannabis, which generates about C$70 million in annual sales with 43 stores in Ontario. Item 9 Labs Corp. CEO Andrew Bowden said the acquisition "fast-tracks our entry into the Canadian market." Shares of Item 9 Labs are down 9.9% in 2022, compared to a drop of 46% by the AdvisorShares Pure US Cannabis ETF .
- PR Newswire
Item 9 Labs Corp. Signs Definitive Agreement to Acquire Sessions Cannabis, One of Canada's Largest Cannabis Retail Franchisors
Item 9 Labs Corp. (OTCQX: INLB) (the "Company") — a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products — announced today that it has signed a definitive agreement to acquire Sessions Cannabis ("Sessions"), one of Canada's largest cannabis retail franchisors.
